LexDanaLexDanabeta
Inventor

Branden Lee

Inventor
San Diego, CA, US

Overview

13→
Patents
2011–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 13 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium16%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%
PatentTitleYear
10,683,298Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors202010,167,290Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors20199,771,371'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20179,193,692'Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors'20159,079,900'Methods of synthesis and purification of heteroaryl compounds'20158,907,087'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20148,569,494'Methods of synthesis and purification of heteroaryl compounds'20138,507,492'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway'20138,492,381'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20138,372,976'Methods of treatment comprising the administration of heteroaryl compounds'20138,299,056'Aminotriazolopyridines, compositions thereof, and methods of treatment therewith'20128,110,578'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20127,981,893'Heteroaryl compounds, compositions thereof, and methods of treatment therewith'2011

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2011–2020Patents assigned to SIGNAL PHARM LLC (13)· patent assignee history
2011–2013Based in Vista, CA, US· patent location history
2012–2013Patents assigned to ELSNER JAN (5)· patent assignee history
2012–2013Patents assigned to PACKARD GARRICK (5)· patent assignee history
2012–2013Patents assigned to PAPA PATRICK (5)· patent assignee history
2012–2013Patents assigned to PERRIN-NINKOVIC SOPHIE (5)· patent assignee history
2012–2013Based in Encinitas, CA, US· patent location history
2013–2020Based in San Diego, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SIGNAL PHARM LLC132011–2020
ELSNER JAN52012–2013
PACKARD GARRICK52012–2013
PAPA PATRICK52012–2013
PERRIN-NINKOVIC SOPHIE52012–2013
Locations
LocationPatentsSpan
San Diego, California, US72013–2020
Encinitas, California, US42012–2013
Vista, California, US22011–2013